



ICICI Venture buys Ranbaxy chemicals bizPosted AtSify.comICICI Venture has acquired the allied
business operations of domestic pharmaceutical major
Ranbaxy Laboratories in a deal that involves management
buyout. The acquisition is valued at Rs 125 croreICICI
Venture and Ranbaxy concluded the deal recently and
Ranbaxy is likely to make an announcement by the end
of this week. ICICI Venture was the front-runner among
potential buyers. Mape Advisory Group, a boutique investment
bank with significant focus on the pharmaceutical sector,
has advised the company on its deal with ICICI Venture. September 02, 2005
|